Skip to content
Saturday, November 7, 2026
Explore the latest technology trends, gadget reviews, and t…

The Zimbabwean Government Declines ‘One-Sided’ US Healthcare Assistance Deal Due to Data Fears

Medical funding illustration
The proposed American funding was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a major American health deal worth 367 million US dollars (272 million pounds) over five years over the United States' request for confidential information.

This move came to light after a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the deal was "skewed".

An official spokesperson has since stated that the United States was seeking health data for scientific study and commercial purposes while was not willing to share the benefits from any future vaccines.

"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for further talks to find a agreement acceptable to both sides so the country's critical HIV programme can proceed.

Broader Context

Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.

Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.

Based on reports, Sixteen African countries have so far agreed to these new health pacts, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration could have provided significant benefits for Zimbabwean communities, especially the 1.2 million presently on HIV treatment via US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," Mangwana explained.

"In essence, our country would supply the raw materials for scientific discovery without any certainty that the resulting innovations would be accessible to our population should a future pandemic arise."

Sovereignty and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks already set up through the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.

"This framework is designed to ensure that when a country provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We encourage continued discussions with our US partners on how future co-operation might be structured in a manner that respects the independence and dignity of each country."

Health Experts Response

A leading public health body stated it understood the government's concerns, but suggested that talks must proceed given that much of the nation's HIV programmes were funded by foreign aid.

"Where technical issues arise, such as those involving data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," the group said.

The halted deal emphasises the continuing debate between receiving crucial foreign assistance and protecting a country's data in an increasingly interconnected world.

The writer

Jennifer Medina

A tech enthusiast and software developer with over a decade of experience in reviewing gadgets and analyzing emerging technologies.

Teknikfloden

Type to search articles.